# Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

Study · id `cardio:ct-nct03257410` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03257410](<https://clinicaltrials.gov/study/NCT03257410>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03257410

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

## Technical summary

Registry record NCT03257410. Randomized; no masking; primary purpose treatment. Start 2017-09-29 (actual); primary completion 2018-10-27 (actual). Results posted on 2020-12-19.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 172 participants (enrolled count; ClinicalTrials.gov record NCT03257410, source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)
- Started: 2017-09-29 (actual) (ClinicalTrials.gov record NCT03257410, source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)
- Primary completion: 2018-10-27 (actual) (ClinicalTrials.gov record NCT03257410, source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)
- Completion: 2018-10-27 (actual) (ClinicalTrials.gov record NCT03257410, source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)
- Results first posted: 2020-12-19 (ClinicalTrials.gov record NCT03257410, source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03257410, source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03257410-2025-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients
- Condition: End Stage Renal Disease
- Intervention (Device): Theranova 400 dialyzer
- Intervention (Device): Elisio-17H dialyzer
- Lead sponsor: Vantive Health LLC
- Lead sponsor class: INDUSTRY
- Collaborator: Baxter Healthcare Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Vantive Health LLC (`cardio:org-vantive-health-llc`)
- Registry lists this organization as a collaborator: Baxter Healthcare Corporation (`cardio:org-baxter-healthcare-corporation`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial (`cardio:pubmed-32843372`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 41d30be64ce0f94a817bc6386da019111b8ab3e8056012069beae0976ec31995
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
